Please login to read the full text of the article.
If you have no account yet, please register now.
Posted on
Previous Article
« Lower survival rates seen with intra-arrest transport Next Article
Higher risk of severe cardiovascular events seen in months after starting ustekinumab therapy »
« Lower survival rates seen with intra-arrest transport Next Article
Higher risk of severe cardiovascular events seen in months after starting ustekinumab therapy »
Related Articles

February 2, 2022
Risankizumab superior to ustekinumab in skin histopathology scores
December 2, 2021
Age at disease onset: a key factor in understanding psoriasis
© 2021 Medicom Medical Publishers. All rights reserved. Terms and Conditions | Privacy Policy